These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 29259527)

  • 1. Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases.
    Chuang K; Fields MA; Del Priore LV
    Yale J Biol Med; 2017 Dec; 90(4):635-642. PubMed ID: 29259527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome Surgery and Gene Therapy in Retinal Disorders.
    Chan L; Mahajan VB; Tsang SH
    Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of CRISPR/Cas9 in retinal degenerative diseases.
    Peng YQ; Tang LS; Yoshida S; Zhou YD
    Int J Ophthalmol; 2017; 10(4):646-651. PubMed ID: 28503441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy and genome surgery in the retina.
    DiCarlo JE; Mahajan VB; Tsang SH
    J Clin Invest; 2018 Jun; 128(6):2177-2188. PubMed ID: 29856367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
    Peddle CF; MacLaren RE
    Yale J Biol Med; 2017 Dec; 90(4):533-541. PubMed ID: 29259519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene editing prospects for treating inherited retinal diseases.
    Benati D; Patrizi C; Recchia A
    J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome editing, a superior therapy for inherited retinal diseases.
    Yan AL; Du SW; Palczewski K
    Vision Res; 2023 May; 206():108192. PubMed ID: 36804635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9 genome engineering: Treating inherited retinal degeneration.
    Burnight ER; Giacalone JC; Cooke JA; Thompson JR; Bohrer LR; Chirco KR; Drack AV; Fingert JH; Worthington KS; Wiley LA; Mullins RF; Stone EM; Tucker BA
    Prog Retin Eye Res; 2018 Jul; 65():28-49. PubMed ID: 29578069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of CRISPR/Cas9 technologies combined with iPSCs in the study and treatment of retinal degenerative diseases.
    Cai B; Sun S; Li Z; Zhang X; Ke Y; Yang J; Li X
    Hum Genet; 2018 Sep; 137(9):679-688. PubMed ID: 30203114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration.
    Burnight ER; Gupta M; Wiley LA; Anfinson KR; Tran A; Triboulet R; Hoffmann JM; Klaahsen DL; Andorf JL; Jiao C; Sohn EH; Adur MK; Ross JW; Mullins RF; Daley GQ; Schlaeger TM; Stone EM; Tucker BA
    Mol Ther; 2017 Sep; 25(9):1999-2013. PubMed ID: 28619647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for inherited retinal diseases: progress and possibilities.
    Hu ML; Edwards TL; O'Hare F; Hickey DG; Wang JH; Liu Z; Ayton LN
    Clin Exp Optom; 2021 May; 104(4):444-454. PubMed ID: 33689657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome Editing in Retinal Diseases using CRISPR Technology.
    Yiu G
    Ophthalmol Retina; 2018 Jan; 2(1):1-3. PubMed ID: 31047294
    [No Abstract]   [Full Text] [Related]  

  • 15. From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing.
    Hotta A; Yamanaka S
    Annu Rev Genet; 2015; 49():47-70. PubMed ID: 26407033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.
    Sanjurjo-Soriano C; Kalatzis V
    Neural Plast; 2018; 2018():5056279. PubMed ID: 29853845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene and cell-based therapies for inherited retinal disorders: An update.
    Sengillo JD; Justus S; Tsai YT; Cabral T; Tsang SH
    Am J Med Genet C Semin Med Genet; 2016 Dec; 172(4):349-366. PubMed ID: 27862925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9 and Its Therapeutic Applications for Retinal Diseases.
    Lin WV; Stout JT; Weng CY
    Int Ophthalmol Clin; 2019; 59(1):3-13. PubMed ID: 30585915
    [No Abstract]   [Full Text] [Related]  

  • 19. CRISPR/Cas9 genome surgery for retinal diseases.
    Xu CL; Park KS; Tsang SH
    Drug Discov Today Technol; 2018 Aug; 28():23-32. PubMed ID: 30205877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized therapeutic strategies for patients with retinitis pigmentosa.
    Zheng A; Li Y; Tsang SH
    Expert Opin Biol Ther; 2015 Mar; 15(3):391-402. PubMed ID: 25613576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.